Twin One Tablet 80/5 mg

Adult dose

The recommended dose of this medication is one tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). In patients with kidney impairment, treatment should start at a lower dose in severe cases, and the dosage should be gradually increased. In patients with liver impairment, the daily dosage of telmisartan should not exceed 40 mg. Elderly patients (75 years and older) should start at a lower dose and gradually

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years, so administration is not recommended.

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy. Women who are pregnant or may become pregnant should not take this medication, and if pregnancy is confirmed, treatment should be discontinued immediately. This medication is contraindicated in individuals with allergies to certain ingredients, severe liver impairment, obstructive biliary diseases, severe hypotension, serious heart disease, and in nursing mothers. Patients with specific heart valve diseases or liver impairment, gastrointestinal disorders, poor kidney function, elderly individuals, etc., should use this medication with caution. Side effects such as dizziness or swelling may commonly occur with this medication, and rare but serious side effects may arise, so any unusual symptoms should be discussed with a physician immediately. Use of this medication should be avoided during pregnancy, particularly due to potential kidney function deterioration or fetal skeletal development issues, and alternative safe medications are recommended if pregnancy is planned. Symptoms of hypotension where blood pressure is too low may appear, so patients with insufficient fluid should improve their status before taking this medication, and blood pressure should be monitored closely after ingestion. There is a risk of elevated potassium levels in the blood, so caution is needed if taken with potassium supplements or medications containing potassium. Patients with impaired kidney function should have their kidney function and electrolyte levels regularly checked through blood tests while taking this medication. This medication may interact with other blood pressure medications or specific drugs, so if taking other medications, it is essential to inform a doctor or pharmacist. Nursing mothers should not take this medication, and the safety and efficacy have not been established for children and adolescents under 18 years, so its use is not recommended. In case of overdose, symptoms such as hypotension, dizziness, irregular heartbeat may occur, and it is urgent to seek appropriate treatment from a medical institution. This medication should be stored in a closed container protected from direct sunlight and kept out of reach of children, with consumption recommended soon after opening the package.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/eye mucosa, difficulty breathing or shortness of breath, asthma attack, respiratory abnormalities accompanied by cough + fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis,

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• urinary tract infection
• cystitis
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia

This medication is sensitive to light, so it must be stored in a container that blocks light. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance

A white and light gray, double convex oval tablet.

Package unit

30 tablets (10 tablets/PTP x 3)